Table 2 Prognostic factors for the time to re-bleeding
Variables | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
Hazard ratio (95% CI) | p value | Hazard ratio (95% CI) | p value | |
Age | 0.977 (0.948–1.007) | 0.129 | ||
ECOG performance status (< 2) | 1.599 (0.669–3.820) | 0.291 | ||
Hematemesis (no) | 1.544 (0.679–3.509) | 0.300 | ||
Hemostasis interventions before radiotherapy (no) | 1.542 (0.678–3.504) | 0.301 | ||
Baseline hemoglobin level | 1.052 (0.824–1.342) | 0.684 | ||
Amount of transfusion before radiotherapy | 1.020 (0.973–1.070) | 0.409 | ||
Biologically effective dose | 0.919 (0.875–0.966) | 0.001 | 0.871 (0.788–0.963) | 0.007 |
Additional chemotherapy after radiotherapy (no) | 0.303 (0.132–0.697) | 0.005 | 0.276 (0.114–0.670) | 0.004 |